Geron (GERN) EV to EBITDA (2010 - 2026)
Geron's (GERN) quarterly EV to EBITDA came in at 41.73 in Q2 2026, down 1.59% year-over-year from 42.41 in Q2 2025, and down 101.03% quarter-over-quarter from 4056.87 in Q1 2026.
Analysis
Geron (GERN) EV to EBITDA (2010 - 2026) Analysis & Trends
Geron has disclosed EV to EBITDA across 17 years of filings, most recently posting 41.73 for Q2 2026.
- In Q2 2026, EV to EBITDA fell 1.59% year-over-year to 41.73; the TTM figure through Jun 2026 stood at 10.07 (down 52.46% YoY), while the FY2025 annual figure was 7.1, up 29.15% from the prior year.
- EV to EBITDA came in at 41.73 for Q2 2026 at Geron, down from 4056.87 in the prior quarter.
- In the past five years, EV to EBITDA ranged from a high of 4056.87 in Q1 2026 to a low of 86.79 in Q4 2024.
- Average EV to EBITDA over 5 years is 195.28, with a median of 22.12 recorded in 2025.
- Year-over-year, EV to EBITDA sank 477.34% in 2024 and jumped 11104.13% in 2026.
- Over 5 years, EV to EBITDA stood at 18.4 in 2022, then grew by 18.28% to 15.03 in 2023, then slumped by 477.34% to 86.79 in 2024, then jumped by 78.04% to 19.06 in 2025, then sank by 119.01% to 41.73 in 2026.
- Per Business Quant data, the three most recent EV to EBITDA figures were 41.73 in Q2 2026, 4056.87 in Q1 2026, and 19.06 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.73 |
| Mar 31, 2026 | 4,056.87 |
| Dec 31, 2025 | -19.06 |
| Sep 30, 2025 | -35.57 |
| Jun 30, 2025 | -41.08 |
| Mar 31, 2025 | -36.87 |
| Dec 31, 2024 | -86.79 |
| Sep 30, 2024 | -85.23 |
| Jun 30, 2024 | -31.63 |
| Mar 31, 2024 | -26.98 |
| Dec 31, 2023 | -15.03 |
| Sep 30, 2023 | -17.60 |
| Jun 30, 2023 | -25.19 |
| Mar 31, 2023 | -18.04 |
| Dec 31, 2022 | -18.40 |
| Sep 30, 2022 | -17.46 |
| Jun 30, 2022 | -13.09 |
| Mar 31, 2022 | -12.09 |
| Dec 31, 2021 | -6.82 |
| Sep 30, 2021 | -10.32 |